4.6 Review

Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Roles of STAT3 in the pathogenesis and treatment of glioblastoma

Weijia Fu et al.

Summary: Glioblastoma (GBM) is a highly malignant brain tumor. The IL6/JAK/STAT3 signaling pathway plays a crucial role in the development and progression of GBM. Abnormal activation of STAT3 in GBM leads to immunosuppression and blocking this pathway can effectively inhibit tumor growth and metastasis. Inhibiting STAT3 may provide a new therapeutic approach for GBM, and combining STAT3 targeted therapy with conventional treatments could improve the current status of GBM treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Review Biology

Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance

Edoardo Agosti et al.

Summary: Despite advancements in molecular discoveries and surgical technologies, the prognosis for glioblastoma (GBM) remains poor. Tumor recurrence, particularly of GBM, could be attributed to the persistence of a subset of cancer cells with stem cell characteristics. The tumor microenvironment (TME) and its interaction with GBM stem cells have been identified as crucial factors in recurrence, making them potential targets for new therapeutic approaches.

BIOLOGY-BASEL (2023)

Review Oncology

The impact of survivorship bias in glioblastoma research

Francesco Pasqualetti et al.

Summary: Despite advances in CNS malignancies therapy, GB treatment remains challenging due to resistance and high recurrence rates. Most predictive GB biomarkers are developed using surgical samples, but selection criteria vary among neurosurgeons, making the patients not representative. Survivorship bias affects biomarkers for patient selection, therapy, and outcome analyses.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Article Oncology

HIF1α/HIF2α induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions

Pan Wang et al.

Summary: The study demonstrated that in a hypoxic microenvironment, the HIF1 alpha/HIF2 alpha-Sox2 network induced the formation of glioma stem cells through the dedifferentiation of differentiated glioma cells, thus promoting glioma cell chemoresistance. Both HIF1 alpha and HIF2 alpha, as genes upstream of Sox2, regulate the malignant progression of glioma through dedifferentiation. The knockout of HIF1 alpha, HIF2 alpha, and Sox2 in glioma cells under hypoxic conditions led to decreased CD133 and CD15 expression and inhibited sphere formation.

JOURNAL OF CANCER (2022)

Article Immunology

The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma

Zeyu Wang et al.

Summary: In this study, the role of the aldehyde dehydrogenase family in gliomas was explored through bulk RNA-seq analysis and single-cell RNA-Seq analysis. The results showed that high-scoring samples based on the aldehyde dehydrogenases family were associated with worse survival outcomes. Pathway enrichment scores were calculated to validate the biofunction prediction results, indicating that the aldehyde dehydrogenases family influenced glioma progression by modulating tumor cell proliferation, migration, and immune landscape. ALDH3B1 and ALDH16A1, two main contributors to the scoring system, were found to affect glioblastoma cell proliferation and migration through cell-cycle arrest and the epithelial-mesenchymal transition.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties

Jimin Park et al.

Summary: This study investigated the potential relationship between the CSC marker CD133 and the master transcription factor NRF2 in colon cancer. The results indicate that the CD133/NRF2 axis plays a critical role in the development of CSC-like properties in colon cancer cells, with activation of the PI3K/AKT signaling pathway involved in CD133-mediated NRF2 activation.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway

N. N. Radharani et al.

Summary: Tumor-associated macrophages (TAMs) promote tumor progression by interacting with breast cancer cells, expressing various proteins, including cytokines that enrich cancer stem cells (CSCs). TAMs produce high levels of Interleukin-6 (IL-6) through p38-MAPK pathway upon interaction with breast cancer cells. TAM-derived IL-6 activates Signal transducer and activator of transcription 3 (STAT-3) pathway, promotes CSC enrichment and influences tumor growth in breast cancer.

CANCER CELL INTERNATIONAL (2022)

Review Biochemistry & Molecular Biology

IDH mutation and cancer stem cell

Yang Zhang et al.

Summary: Cancer stem cells (CSCs) have a close relationship with oncogenesis, disease progression, therapeutic resistance, and overall outcome. Mutations in isocitrate dehydrogenase (IDH) are closely related to the establishment and maintenance of CSCs, leading to distinctive molecular signatures. IDH mutation and IDH-related pathways could be valuable molecular targets to improve the disease outcome.

ESSAYS IN BIOCHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression

Chenkai Ma et al.

Summary: This study found that extracellular vesicles (EVs) secreted by glioma stem cells (GSC-EVs) have the potential to induce radiation resistance and promote glioma progression. GSC-EVs activate the PTEN/Akt pathway in recipient cells through specific miRNAs, leading to phenotypic changes and increased cell migration and colony formation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Epidemiology of Glioblastoma Multiforme-Literature Review

Szymon Grochans et al.

Summary: Glioblastoma multiforme (GBM) is a highly aggressive malignancy with a median overall survival of approximately 15 months. This review analyzes the pathogenesis and epidemiological data of GBM, including age, gender, and tumor location. The data suggest that GBM is a higher-grade primary brain tumor and is significantly more common in men. Despite advancements in medicine, the risk of being diagnosed with glioma increases with age and median survival remains low. Additionally, the influence of stimulants, certain medications (such as NSAIDs), cell phone use, and exposure to heavy metals on GBM is difficult to determine clearly.

CANCERS (2022)

Article Oncology

Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy

Jang Hyun Park et al.

Summary: Glioblastoma multiforme (GBM) is an aggressive tumor in the central nervous system, and its survival is affected by hypoxia, which promotes drug resistance and inhibits immune responses. Traditionally, hypoxia studies have focused on blood vessels and tumor cells, excluding the immune system. However, recent evidence suggests the important role of immunosurveillance in tumor hypoxia. This review discusses the clinical, pathological, and immunological perspectives of hypoxia in GBM.

CANCERS (2022)

Review Medicine, General & Internal

Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance

Michele Zanoni et al.

Summary: Aldehyde dehydrogenases (ALDHs) are detoxifying enzymes often upregulated in cancer cells and associated with therapeutic resistance. ALDHs have various functions in cancer stem cells and immune cells, playing a crucial role in cancer treatment.

FRONTIERS IN MEDICINE (2022)

Review Immunology

Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications

Guanglin Cui et al.

Summary: The development of colorectal cancer is closely related to cytokines, which play an important role in the regulation of pCSC/CSC properties and features.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands

Jian Zhong et al.

Summary: This study revealed that the overexpression of EZH2-92aa in Glioblastoma leads to immune evasion of the tumor cells from NK cells. EZH2-92aa directly binds and represses the transcription of MICA/B, and indirectly represses ULBP transcription by stabilizing EZH2. Knockdown of EZH2-92aa enhances NK cell-mediated eradication of GSCs and synergizes with anti-PD1 therapy.

NATURE COMMUNICATIONS (2022)

Review Cell Biology

The emerging role of exosomes in radiotherapy

Zhenyi Yang et al.

Summary: Radiotherapy is commonly used in cancer treatment, but radioresistance and radiation-induced bystander effects remain challenging. Exosomes play a significant role in radiotherapy by mediating intercellular signaling pathways and participating in the mechanisms of radioresistance and radiation-induced bystander effects.

CELL COMMUNICATION AND SIGNALING (2022)

Review Oncology

New perspectives in liquid biopsy for glioma patients

Francesco Pasqualetti et al.

Summary: Although studies on the use of liquid biopsy are still at an early stage, the potential clinical applications of liquid biopsy in the study of primary brain cancer are many and have the potential to revolutionize the approach to neuro-oncology, and importantly, they offer the possibility of gathering information on the disease at any time during its history.

CURRENT OPINION IN ONCOLOGY (2022)

Review Cell & Tissue Engineering

Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems

Aadya Nayak et al.

Summary: The physiological state of the tumor microenvironment is crucial in cancer development and offers ideal targets for diagnostic and therapeutic approaches, particularly in nanomedical derivates like nanocarriers. However, the broad spectrum of targeting possibilities within TMEs presents challenges in effective utilization.

STEM CELL REVIEWS AND REPORTS (2022)

Article Cell Biology

EZH2 is a potential prognostic predictor of glioma

Yi-nan Chen et al.

Summary: The study found that the expression of EZH2 in glioma is significantly correlated with clinicopathologic characteristics and overall survival rate, suggesting its potential as a prognostic molecular marker. Additionally, the research identified associations between EZH2 and signaling pathways related to the cell cycle, DNA replication, and immune checkpoints.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Oncology

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller et al.

Summary: The European Association of Neuro-Oncology (EANO) has released guidelines for the diagnosis, treatment, and follow-up of adult patients with diffuse gliomas, incorporating major changes in diagnostic algorithms based on the 2016 update of the WHO Classification of Tumors of the Central Nervous System, as well as evidence from recent large clinical trials.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Oncology

Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing

Alexander E. Kabakov et al.

Summary: Certain cancer cells become more resistant to radiation under hypoxic conditions, decreasing the efficacy of radiotherapy for hypoxic tumors. Understanding the mechanisms by which cancer cells adapt to hypoxia can help improve the sensitivity of hypoxic tumors to radiotherapy.

CANCERS (2021)

Article Cell Biology

SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer

Yin Zhu et al.

Summary: The study elucidated the mechanisms by which SOX2 regulates ABCC2 in colorectal cancer, along with beta-catenin, Beclin1, and autophagy signaling, affecting chemoresistance, stemness, and EMT. Clinical analyses revealed a positive correlation between high ABCC2 and Beclin1 expression with SOX2, associated with poor prognosis in CRC patients. Xenograft models confirmed that inhibition of SOX2 expression and autophagy restrained tumor growth and chemoresistance in vivo.

CELL DEATH & DISEASE (2021)

Review Oncology

Metastasis-Initiating Cells and Ecosystems

Joan Massague et al.

Summary: Metastasis-initiating cells (MIC) are cancer cells with stem-like and immune-evasive properties that adopt regenerative progenitor phenotypes, enabling them to survive the stresses of metastasis and evade immune surveillance. Understanding the molecular mechanisms of MIC phenotypes and host tissue ecosystems is crucial for developing improved cancer therapeutics.

CANCER DISCOVERY (2021)

Review Cell & Tissue Engineering

Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives

Ana Laura V. Alves et al.

Summary: Glioblastoma (GBM) is the highest-grade form of glioma, characterized by rapid cellular growth and high invasiveness. Understanding cancer stem cells (CSCs) has provided new insights into GBM resistance and management. With knowledge of GSCs and therapies based on antineoplastic agents, a promising future in GBM treatment may be on the horizon.

STEM CELL RESEARCH & THERAPY (2021)

Review Gastroenterology & Hepatology

Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications

Terence Kin-Wah Lee et al.

Summary: Hepatocellular carcinoma (HCC) is an aggressive disease with poor prognosis, powered by a subset of cancer stem cells (CSCs). Research on liver CSCs has revealed their heterogeneity and unique immunobiology, suggesting potential for new research directions and therapies for HCC.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Oncology

Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies

Abigail Harland et al.

Summary: This review explores the characteristics of glioma stem-like cells (GSCs), their metabolic interactions, and potential strategies for overcoming GSC resistance.

FRONTIERS IN ONCOLOGY (2021)

Review Cell & Tissue Engineering

Immune evasion by cancer stem cells

Hiroyuki Tsuchiya et al.

Summary: Tumor immunity represents a novel approach to cancer therapy, with immune checkpoint inhibitors showing success in several tumor types, but further improvement in efficacy is needed. The mechanisms of cancer cell evasion of the immune response require further research, with cancer stem cells playing a crucial role in this process.

REGENERATIVE THERAPY (2021)

Review Oncology

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance

Andriy Marusyk et al.

CANCER CELL (2020)

Article Oncology

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas

Daolin Si et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Article Cell Biology

The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape

Sara Bruschini et al.

CELL DEATH & DISEASE (2020)

Article Pharmacology & Pharmacy

Tim-3 Expression and MGMT Methylation Status Association With Survival in Glioblastoma

Ji Zhang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Cell Biology

EZH2-Inhibited MicroRNA-454-3p Promotes M2 Macrophage Polarization in Glioma

Bin Qi et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Phenotypic and Functional Characteristics of Exosomes Derived from Irradiated Mouse Organs and Their Role in the Mechanisms Driving Non-Targeted Effects

Seda Tuncay Cagatay et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cell Biology

Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis

Wei Lu et al.

DEVELOPMENTAL CELL (2019)

Review Oncology

Cancer Stem Cells and Radioresistance: DNA Repair and Beyond

Alexander Schulz et al.

CANCERS (2019)

Review Oncology

Exosomes in Cancer Radioresistance

Jie Ni et al.

FRONTIERS IN ONCOLOGY (2019)

Review Oncology

Molecular targeted therapy of glioblastoma

Emilie Le Rhun et al.

CANCER TREATMENT REVIEWS (2019)

Article Biochemistry & Molecular Biology

The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment

Mitsuru Futakuchi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Medicine, Research & Experimental

Cancer stem cell (CSC) resistance drivers

Masoud Najafi et al.

LIFE SCIENCES (2019)

Review Cell & Tissue Engineering

Cancer Stem Cells: The Architects of the Tumor Ecosystem

Briana C. Prager et al.

CELL STEM CELL (2019)

Review Biochemistry & Molecular Biology

ROS and the DNA damage response in cancer

Upadhyayula Sai Srinivas et al.

REDOX BIOLOGY (2019)

Review Oncology

Cancer stem cell in breast cancer therapeutic resistance

Xupeng Bai et al.

CANCER TREATMENT REVIEWS (2018)

Review Biochemistry & Molecular Biology

Nestin-expressing progenitor cells: function, identity and therapeutic implications

Aurora Bernal et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Editorial Material Biotechnology & Applied Microbiology

Basic and Translational Advances in Glioblastoma

Sara G. M. Piccirillo et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Cell & Tissue Engineering

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

Lan Thi Hanh Phi et al.

STEM CELLS INTERNATIONAL (2018)

Review Endocrinology & Metabolism

Role of AHR and HIF-1α in Glioblastoma Metabolism

Galina Gabriely et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)

Article Oncology

Notch1 ablation radiosensitizes glioblastoma cells

Na Han et al.

ONCOTARGET (2017)

Review Cell Biology

CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells

Linda T. Senbanjo et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)

Article Oncology

Cancer stem cells and signaling pathways in radioresistance

Lei Chang et al.

ONCOTARGET (2016)

Article Pharmacology & Pharmacy

mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance

Laura Garros-Regulez et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2016)

Article Biochemistry & Molecular Biology

CD44: More than a mere stem cell marker

I. Morath et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)

Review Cell & Tissue Engineering

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Ranjeeta Thapa et al.

STEM CELLS INTERNATIONAL (2016)

Review Oncology

Hypoxia: Signaling the Metastatic Cascade

Erinn B. Rankin et al.

TRENDS IN CANCER (2016)

Article Biochemistry & Molecular Biology

Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K

Rupert Courtnay et al.

MOLECULAR BIOLOGY REPORTS (2015)

Article Cell & Tissue Engineering

EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXMI-Dependent Manner

Sung-Hak Kim et al.

STEM CELL REPORTS (2015)

Review Biochemistry & Molecular Biology

Redox- Modulated Phenomena and Radiation Therapy: The Central Role of Superoxide Dismutases

Aaron K. Holley et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Article Biology

Cancer stem cells and radioresistance

Kiera Rycaj et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Mechanisms Governing Metastatic Dormancy and Reactivation

Filippo G. Giancotti

Review Cell Biology

The multiple roles for Sox2 in stem cell maintenance and tumorigenesis

Kuancan Liu et al.

CELLULAR SIGNALLING (2013)

Review Biochemistry & Molecular Biology

Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress

Surendra Singh et al.

FREE RADICAL BIOLOGY AND MEDICINE (2013)

Article Multidisciplinary Sciences

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3

Ping Mao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Medicine, Research & Experimental

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity

Jessian L. Munoz et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2013)

Review Oncology

Mechanisms of chemoresistance in cancer stem cells

Lissa Nurrul Abdullah et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2013)

Article Oncology

Analysis of exosome release and its prognostic value in human colorectal cancer

J. Silva et al.

GENES CHROMOSOMES & CANCER (2012)

Article Cell Biology

Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma

Adrian M. Jubb et al.

HISTOPATHOLOGY (2012)

Article Biochemistry & Molecular Biology

Oct-3/4 promotes migration and invasion of glioblastoma cells

Kana Kobayashi et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2012)

Article Multidisciplinary Sciences

A restricted cell population propagates glioblastoma growth after chemotherapy

Jian Chen et al.

NATURE (2012)

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Oncology

Chk1 knockdown confers radiosensitization in prostate cancer stem cells

Xiaobin Wang et al.

ONCOLOGY REPORTS (2012)

Article Cell & Tissue Engineering

Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells

Kristel Kemper et al.

STEM CELLS (2012)

Editorial Material Cell Biology

Notch Signaling

Raphael Kopan

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Article Urology & Nephrology

Exosomes as Biomarker Treasure Chests for Prostate Cancer

Diederick Duijvesz et al.

EUROPEAN UROLOGY (2011)

Article Multidisciplinary Sciences

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Maximilian Diehn et al.

NATURE (2009)

Article Oncology

Therapeutic Implications of the Cancer Stem Cell Hypothesis

Maximilian Diehn et al.

SEMINARS IN RADIATION ONCOLOGY (2009)

Article Cell & Tissue Engineering

STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells

Maureen M. Sherry et al.

STEM CELLS (2009)

Article Oncology

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients

Mingyu Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)

Article Biochemistry & Molecular Biology

Identification and expansion of the tumorigenic lung cancer stem cell population

A. Eramo et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Multidisciplinary Sciences

WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells

Wendy A. Woodward et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Oncology

A perivascular niche for brain tumor stem cells

Christopher Calabrese et al.

CANCER CELL (2007)

Article Oncology

The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation

Tiffany M. Phillips et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Multidisciplinary Sciences

Identification of human brain tumour initiating cells

SK Singh et al.

NATURE (2004)

Article Multidisciplinary Sciences

Prospective identification of tumorigenic breast cancer cells

M Al-Hajj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)